Literature DB >> 10677418

Increased serum neopterin: a marker of coronary artery disease activity in women.

X Garcia-Moll1, D Cole, E Zouridakis, J C Kaski.   

Abstract

OBJECTIVE: To assess whether neopterin concentrations in women with unstable angina differ from those in women with chronic stable angina.
DESIGN: Prospective cohort study.
SETTING: University hospital in south west London. PATIENTS: 114 consecutive women with angina were studied: 82 had chronic stable angina (typical exertional chest pain, positive exercise ECG testing, and/or abnormal myocardial scintigraphy; symptoms stable for at least three months), and 32 had unstable angina (Braunwald class III). All patients with chronic stable angina (100%) and 18 with unstable angina (56.3%) underwent digital coronary angiography; neopterin concentrations were determined using a commercially available immunoassay. MAIN OUTCOME MEASURES: Major clinical events during one year follow up were readmission with Braunwald's class IIIb unstable angina, non-fatal myocardial infarction, and cardiac death.
RESULTS: Major events occurred in 12 women with chronic stable angina (14.6%) and nine women with unstable angina (28.1%). Mean (range) neopterin concentrations were significantly higher in women with unstable angina than in those with chronic stable angina (7.6 (5.1-11.5) nmol/l v 5.9 (4.4-7.5) nmol/l; p = 0.003), even after adjustment for variables which were significantly different on univariate analysis. In women with chronic stable angina, baseline neopterin concentrations were higher in those with cardiac events than in those without events (7.1 (5.9-9.1) nmol/l v 5.7 (3.9-7.3 nmol/l); p = 0.010), even after adjustment for variables with significant differences between both groups on univariate analysis.
CONCLUSIONS: On average, women with unstable angina had significantly higher neopterin concentrations than women with chronic stable angina. Women with chronic stable angina with events during follow up had higher neopterin concentrations than those without events. Neopterin concentrations were similar in patients with unstable angina and women with chronic stable angina who developed events. Neopterin concentrations may therefore be a marker of risk in women with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677418      PMCID: PMC1729345          DOI: 10.1136/heart.83.3.346

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  28 in total

1.  Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP.

Authors:  G Werner-Felmayer; E R Werner; D Fuchs; A Hausen; G Reibnegger; K Schmidt; G Weiss; H Wachter
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

2.  Unstable angina. A classification.

Authors:  E Braunwald
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

3.  Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction.

Authors:  E P Gurfinkel; B M Scirica; G Bozovich; A Macchia; E Manos; B Mautner
Journal:  Am J Cardiol       Date:  1999-02-15       Impact factor: 2.778

Review 4.  Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.

Authors:  T Collins
Journal:  Lab Invest       Date:  1993-05       Impact factor: 5.662

5.  Elevated serum neopterin levels in atherosclerosis.

Authors:  F Tatzber; H Rabl; K Koriska; U Erhart; H Puhl; G Waeg; A Krebs; H Esterbauer
Journal:  Atherosclerosis       Date:  1991-08       Impact factor: 5.162

6.  Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.

Authors:  P R Moreno; E Falk; I F Palacios; J B Newell; V Fuster; J T Fallon
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

7.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

Authors:  A C van der Wal; A E Becker; C M van der Loos; P K Das
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

8.  Transient intermittent lymphocyte activation is responsible for the instability of angina.

Authors:  G G Serneri; R Abbate; A M Gori; M Attanasio; F Martini; B Giusti; P Dabizzi; L Poggesi; P A Modesti; F Trotta
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

9.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

Authors:  G Liuzzo; L M Biasucci; J R Gallimore; R L Grillo; A G Rebuzzi; M B Pepys; A Maseri
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

10.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  10 in total

1.  Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography.

Authors:  C Özbek; I Baran; A Tütüncü; T Kuştarcı; K Karaağaç; A Özbek
Journal:  Ir J Med Sci       Date:  2013-08-29       Impact factor: 1.568

2.  Sorting through new biomarkers.

Authors:  Frances O Wood; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

3.  Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes.

Authors:  M Ragab; H Hassan; T Zaytoun; W Refai; B Rocks; M Elsammak
Journal:  Exp Clin Cardiol       Date:  2005

Review 4.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

5.  Highly efficient SERS-based detection of cerebrospinal fluid neopterin as a diagnostic marker of bacterial infection.

Authors:  Agnieszka Kamińska; Evelin Witkowska; Aneta Kowalska; Anna Skoczyńska; Iwona Gawryszewska; Elżbieta Guziewicz; Dymitr Snigurenko; Jacek Waluk
Journal:  Anal Bioanal Chem       Date:  2016-04-16       Impact factor: 4.142

6.  Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study.

Authors:  Shu-Chun Chuang; Heiner Boeing; Stein Emil Vollset; Øivind Midttun; Per Magne Ueland; Bas Bueno-de-Mesquita; Martin Lajous; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Rudolf Kaaks; Tilman Küehn; Tobias Pischon; Dagmar Drogan; Anne Tjønneland; Kim Overvad; J Ramón Quirós; Antonio Agudo; Esther Molina-Montes; Miren Dorronsoro; José María Huerta; Aurelio Barricarte; Kay-Tee Khaw; Nicholas J Wareham; Ruth C Travis; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Giovanna Masala; Claudia Agnoli; Rosario Tumino; Amalia Mattiello; Petra H Peeters; Elisabete Weiderpass; Richard Palmqvist; Ingrid Ljuslinder; Marc Gunter; Yunxia Lu; Amanda J Cross; Elio Riboli; Paolo Vineis; Krasimira Aleksandrova
Journal:  Immun Ageing       Date:  2016-02-25       Impact factor: 6.400

7.  Associations of plasma hepcidin with mortality risk in patients with coronary artery disease.

Authors:  Xinrui Li; Ding Ding; Yuan Zhang; Dongfang Su; Min Wang; Xuechen Chen; Yan Yang; Changjiang Hong; Gang Hu; Wenhua Ling
Journal:  Oncotarget       Date:  2017-11-27

8.  Important Biomarkers that Play a Role in the Chronic Obstructive Pulmonary Disease Process.

Authors:  Emre Avci; Gulcin Alp Avci
Journal:  J Med Biochem       Date:  2018-01-01       Impact factor: 3.402

9.  Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.

Authors:  Edward C A Marks; Tom M Wilkinson; Chris M Frampton; Lorraine Skelton; Anna P Pilbrow; Tim G Yandle; Chris J Pemberton; Robert N Doughty; Gillian A Whalley; Chris J Ellis; Richard W Troughton; Maurice C Owen; Neil R Pattinson; Vicky A Cameron; A Mark Richards; Steven P Gieseg; Barry R Palmer
Journal:  BMC Cardiovasc Disord       Date:  2018-08-15       Impact factor: 2.298

10.  Potential Markers in Cardiac Hypertrophy?

Authors:  Bartosz Malinowski; Gabriele Fulgheri; Michal Wicinski; Elzbieta Grzesk; Grazyna Odrowaz-Sypniewska; Grzegorz Grześk; Nasser Darwish
Journal:  EJIFCC       Date:  2012-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.